REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 35 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $21,000 | +250.0% | 40,545 | -0.0% | 0.00% | – |
| Q4 2016 | $6,000 | -33.3% | 40,546 | +0.0% | 0.00% | – |
| Q3 2016 | $9,000 | -25.0% | 40,545 | -16.1% | 0.00% | – |
| Q2 2016 | $12,000 | -25.0% | 48,337 | -0.8% | 0.00% | – |
| Q1 2016 | $16,000 | +6.7% | 48,703 | +20.1% | 0.00% | – |
| Q4 2015 | $15,000 | -28.6% | 40,545 | -0.0% | 0.00% | – |
| Q3 2015 | $21,000 | -41.7% | 40,546 | -31.7% | 0.00% | – |
| Q2 2015 | $36,000 | -18.2% | 59,346 | 0.0% | 0.00% | – |
| Q1 2015 | $44,000 | -48.2% | 59,346 | -51.4% | 0.00% | – |
| Q4 2014 | $85,000 | -33.6% | 122,058 | -22.8% | 0.00% | – |
| Q3 2014 | $128,000 | +141.5% | 158,033 | +156.3% | 0.00% | – |
| Q2 2014 | $53,000 | -45.9% | 61,661 | -32.1% | 0.00% | – |
| Q1 2014 | $98,000 | +366.7% | 90,760 | +125.6% | 0.00% | – |
| Q4 2013 | $21,000 | +10.5% | 40,230 | 0.0% | 0.00% | – |
| Q3 2013 | $19,000 | +5.6% | 40,230 | 0.0% | 0.00% | – |
| Q2 2013 | $18,000 | +200.0% | 40,230 | +114.0% | 0.00% | – |
| Q4 2012 | $6,000 | -70.0% | 18,800 | -53.3% | 0.00% | – |
| Q3 2012 | $20,000 | +53.8% | 40,230 | -0.3% | 0.00% | – |
| Q2 2012 | $13,000 | -38.1% | 40,367 | +0.3% | 0.00% | – |
| Q1 2012 | $21,000 | – | 40,246 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 18,340,000 | $3,852,000 | 0.41% |
| SABBY MANAGEMENT, LLC | 9,464,849 | $1,988,000 | 0.07% |
| Northeast Financial Consultants Inc | 150,000 | $31,000 | 0.01% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 200,000 | $42,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 185,239 | $39,000 | 0.01% |
| Benin Management CORP | 93,000 | $20,000 | 0.01% |
| CONDOR CAPITAL MANAGEMENT | 145,000 | $30,000 | 0.01% |
| NIXON PEABODY TRUST CO | 10,000 | $2,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 47,677 | $10,000 | 0.00% |
| Renaissance Technologies | 3,201,993 | $672,000 | 0.00% |